Abstract
To assess depressive symptoms severity and dispositional optimism in patients with recent onset arthritis both before and after 4 months treatment. Two hundred twenty-two patients with recent onset RA and undifferentiated arthritis in the IMPROVED study filled out the Beck Depression Inventory (BDI-II) to assess depressive symptoms severity and the Life Orientation Test Revised (LOT-R) to measure optimism before and after 4 months of treatment. All patients were treated with methotrexate 25 mg/week and prednisone 60 mg/day (tapered to 7.5 mg/day in 7 weeks). Linear regression analysis was used to assess the association between the disease activity score (DAS) and its components (tender joint count, general well-being measured with a visual analogue scale (VAS), swollen joint count, and erythrocyte sedimentation rate) with the BDI-II an LOT-R scores. In general, depressive symptoms were mild. The DAS was an independent predictor of depressive symptoms scores both at baseline and after 4 months follow-up, in particular tender joint count and VAS global health. Disease activity was not associated with the level of optimism. Nevertheless, patients who achieved clinical remission improved significantly more in both depression score and optimism score than patients who did not. Patients with early arthritis report improvement in depressive symptoms and optimism with improvement in disease activity and achieving clinical remission. Depression scores are associated with pain and unwell being but not with swollen joint counts and inflammatory parameters.
Similar content being viewed by others
References
Dickens C, McGowan L, Clark-Carter D, Creed F (2002) Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 64:52–60
Covic T, Tyson G, Spencer D, Howe G (2006) Depression in rheumatoid arthritis patients: demographic, clinical, and psychological predictors. J Psychosom Res 60:469–476
Kekow J, Moots R, Khandker R, Melin J, Freundlich B, Singh A (2011) Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology (Oxford) 50:401–409
Pincus T, Griffith J, Pearce S, Isenberg D (1996) Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol 35:879–883
O’Brien SM, Scott LV, Dinan TG (2004) Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 19:397–403
Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9:853–858
Da Silva JA, Jacobs JW, Kirwan JR, Boers M, Saag KG, Ines LB et al (2006) Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 65:285–293
Fietta P, Fietta P, Delsante G (2009) Central nervous system effects of natural and synthetic glucocorticoids. Psychiatr Clin Neurosci 63:613–622
Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R et al (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68:1119–1124
Brown ES (2009) Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 1179:41–55
Scheier MF, Carver CS (1985) Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol 4:219–247
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588
Siegert CE, Vleming LJ, Vandenbroucke JP, Cats A (1984) Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 3:305–309
Beck A (2002) BDI-II-NL: De nederlandse versie van de Beck depression inventory 2nd ed
Scheier MF, Carver CS, Bridges MW (1994) Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation test. J Pers Soc Psychol 67:1063–1078
van de Rest O, de Goede J, Sytsma F, Oude Griep LM, Geleijnse JM, Kromhout D et al (2010) Association of n-3 long-chain PUFA and fish intake with depressive symptoms and low dispositional optimism in older subjects with a history of myocardial infarction. Br J Nutr 103:1381–1387
Zenger M, Glaesmer H, Hockel M, Hinz A (2011) Pessimism predicts anxiety, depression and quality of life in female cancer patients. Jpn J Clin Oncol 41:87–94
Prevoo ML, van Gestel AM, van’t Hof M, van Rijswijk MH, van de Putte LB, van Riel PL (1996) Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 35:1101–1105
Margaretten M, Julian L, Katz P, Yelin E (2011) Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol 6:617–623
Ryerson CJ, Arean PA, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS et al (2012) Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology 17:525–532
Spiegel D, Sands S, Koopman C (1994) Pain and depression in patients with cancer. Cancer 74:2570–2578
Brown GK, Nicassio PM, Wallston KA (1989) Pain coping strategies and depression in rheumatoid arthritis. J Consult Clin Psychol 57:652–657
Wrosch C, Scheier MF (2003) Personality and quality of life: the importance of optimism and goal adjustment. Qual Life Res 12(Suppl 1):59–72
Geers AL, Wellman JA, Helfer SG, Fowler SL, France CR (2008) Dispositional optimism and thoughts of well-being determine sensitivity to an experimental pain task. Ann Behav Med 36:304–313
Kurtz ME, Kurtz JC, Given CW, Given BA (2008) Patient optimism and mastery-do they play a role in cancer patients' management of pain and fatigue? J Pain Symptom Manage 36:1–10
Fournier M, De Ridder D, Bensing J (2002) Optimism and adaptation to chronic disease: the role of optimism in relation to self-care options of type 1 diabetes mellitus, rheumatoid arthritis and multiple sclerosis. Br J Health Psychol 7:409–432
McBain H, Shipley M, Newman S (2012) The impact of appearance concerns on depression and anxiety in rheumatoid arthritis. Muscoskel Care
van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P (2010) Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 49:1294–1302
Acknowledgments
We would like to thank all patients as well as the following rheumatologists (other than the authors) who participated in the IMPROVED study group (registered in the ISRCTN register number 11916566 and the EudraCT number 2006-006186-16) (all locations are in The Netherlands): W.M. de Beus (Medical Center Haaglanden, Leidschendam), C. Bijkerk (Reinier de Graaf Gasthuis, Delft), M.H.W. de Bois (Medical Center Haaglanden, The Hague), M. de Buck (Medical Center Haaglanden, Leidschendam), G. Collée (Medical Center Haaglanden, The Hague), J.A.P.M. Ewals (Haga Hospital, The Hague), R.J. Goekoop (Haga Hospital, The Hague), Y.P.M. Goekoop-Ruiterman (Haga Hospital, The Hague), B.A.M. Grillet (Zorgsaam, Terneuzen), J.H.L.M. van Groenendael (Franciscus Hospital, Roosendaal), L.R. Lard (Medical Center Haaglanden, Leidschendam), E.T.H. Molenaar (Groene Hart Hospital, Gouda), A.J. Peeters (Reinier de Graaf Gasthuis, Delft), N. Riyazi (Haga hospital, The Hague), A.A. Schouffoer (Groene Hart Hospital, Gouda), P.E.H. Seys (Lievensberg hospital, Bergen op Zoom), P.B.J. de Sonnaville (Oosterschelde Hospital, Goes), I. Speyer (Bronovo Hospital, The Hague), and M.L. Westedt (Bronovo Hospital, The Hague). We would also like to thank all other rheumatologists and trainee rheumatologists who enrolled patients in this study and all research nurses for their contributions.
Funding
The study was designed by the investigators and financially supported by Abbott. Data collection, trial management, data analyses, and preparation of the manuscript were performed by the authors.
Disclosures
Dr Huizinga and Allaart received speaker fees from various companies, each less than $5,000 per year. The other authors have disclosed no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heimans, L., Wevers-de Boer, K.V.C., Visser, K. et al. The relationship between disease activity and depressivesymptoms severity and optimism—results from the IMPROVED study. Clin Rheumatol 32, 1751–1757 (2013). https://doi.org/10.1007/s10067-013-2337-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2337-9